Cell Source, Inc.
Cell Source, Inc. is listed today as Cell Source, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2020 | $4 M | Private placement after listing | $2 to $10 million | debt, options | SEC | |
| Sep 2016 | $9 M | Private placement after listing | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Cell Source, Inc. had no revenue when it filed its newest notice of a funding round (Oct 2023).
SEC Form D (revenue range) · Oct 2023
The industry group it chose in its notices: Biotechnology.
SEC Form D · Oct 2023
Products and services#
No products or services of Cell Source, Inc. are on record.
Investors#
1 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Darlene Soave | Person | not stated | not stated | Held Series A preferred stock, director (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding Cell Source, Inc. shares, as of Sep 30, 2026.
- Planning Project LLC$0 M—
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Itamar Shimrat | Executive officer | Oct 2023 |
| Darlene Soave | Represents salary paid to the President and Chief Executive Officer of the Issuer in 2021 and 2022. | Oct 2023 |
| Dennis Brown | Director | Oct 2023 |
| George Verstraete | Director | Oct 2023 |
| Itamar Shimrat | Director | Oct 2019 |
Went public since 2015. Its SEC number is that of a company listed on a stock exchange.